Merit Medical Systems, Inc. (NASDAQ:MMSI) Expected to Announce Quarterly Sales of $263.46 Million

Brokerages predict that Merit Medical Systems, Inc. (NASDAQ:MMSIGet Rating) will post sales of $263.46 million for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Merit Medical Systems’ earnings. The highest sales estimate is $265.42 million and the lowest is $261.69 million. Merit Medical Systems reported sales of $248.91 million in the same quarter last year, which would suggest a positive year over year growth rate of 5.8%. The business is expected to report its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Merit Medical Systems will report full year sales of $1.13 billion for the current year, with estimates ranging from $1.12 billion to $1.13 billion. For the next fiscal year, analysts anticipate that the business will report sales of $1.19 billion, with estimates ranging from $1.18 billion to $1.19 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that cover Merit Medical Systems.

Merit Medical Systems (NASDAQ:MMSIGet Rating) last issued its quarterly earnings results on Thursday, February 24th. The medical instruments supplier reported $0.71 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.21. The firm had revenue of $278.50 million for the quarter, compared to analysts’ expectations of $270.96 million. Merit Medical Systems had a return on equity of 13.54% and a net margin of 4.51%. Merit Medical Systems’s revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the business posted $0.54 EPS.

Several equities analysts have weighed in on MMSI shares. Barrington Research lifted their target price on Merit Medical Systems from $78.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 25th. Raymond James lowered their target price on Merit Medical Systems from $73.00 to $72.00 and set an “outperform” rating on the stock in a research note on Friday, February 25th. TheStreet raised Merit Medical Systems from a “c” rating to a “b-” rating in a research note on Friday, February 25th. Piper Sandler lowered their target price on Merit Medical Systems from $79.00 to $75.00 in a research note on Friday, February 25th. Finally, Needham & Company LLC lowered their target price on Merit Medical Systems from $83.00 to $73.00 and set a “buy” rating on the stock in a research note on Friday, February 25th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Merit Medical Systems currently has a consensus rating of “Buy” and an average price target of $75.20.

Several hedge funds and other institutional investors have recently made changes to their positions in MMSI. BlackRock Inc. lifted its holdings in Merit Medical Systems by 10.8% in the 4th quarter. BlackRock Inc. now owns 8,334,516 shares of the medical instruments supplier’s stock worth $519,240,000 after purchasing an additional 809,628 shares during the last quarter. Conestoga Capital Advisors LLC lifted its holdings in Merit Medical Systems by 4.9% in the 4th quarter. Conestoga Capital Advisors LLC now owns 2,510,787 shares of the medical instruments supplier’s stock worth $156,422,000 after purchasing an additional 117,795 shares during the last quarter. State Street Corp lifted its holdings in Merit Medical Systems by 3.2% in the 4th quarter. State Street Corp now owns 1,914,449 shares of the medical instruments supplier’s stock worth $119,270,000 after purchasing an additional 58,884 shares during the last quarter. Macquarie Group Ltd. lifted its holdings in Merit Medical Systems by 1.0% in the 3rd quarter. Macquarie Group Ltd. now owns 1,439,274 shares of the medical instruments supplier’s stock worth $103,340,000 after purchasing an additional 14,291 shares during the last quarter. Finally, Westwood Holdings Group Inc. lifted its holdings in Merit Medical Systems by 40.1% in the 4th quarter. Westwood Holdings Group Inc. now owns 1,182,149 shares of the medical instruments supplier’s stock worth $73,648,000 after purchasing an additional 338,655 shares during the last quarter. 95.93% of the stock is owned by institutional investors and hedge funds.

NASDAQ:MMSI traded down $0.60 on Friday, hitting $67.41. 8,414 shares of the company’s stock traded hands, compared to its average volume of 350,413. The company has a current ratio of 2.04, a quick ratio of 1.10 and a debt-to-equity ratio of 0.23. Merit Medical Systems has a 1 year low of $51.66 and a 1 year high of $73.85. The firm has a 50-day moving average price of $61.89 and a 200-day moving average price of $63.99. The company has a market cap of $3.81 billion, a PE ratio of 79.60, a price-to-earnings-growth ratio of 2.60 and a beta of 1.03.

Merit Medical Systems Company Profile (Get Rating)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

See Also

Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.